ArticleBiomedical reports2023

Inhibition of SGK1 potentiates the anticancer activity of PI3K inhibitor in NSCLC cells through modulation of mTORC1, p‑ERK and β‑catenin signaling.

Ramesh Kale et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.